Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cellular Immunology
|
October 9, 2012
T cell subsets and colorectal cancer: discerning the good from the bad
Martin Scurr, Awen Gallimore, Andrew Godkin
Immunology
|
February 21, 2018
T-cell modulation by cyclophosphamide for tumour therapy
Ellyn Hughes, Martin Scurr, Emma Campbell, et al.
International Journal of Hematology
|
February 9, 2023
Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T
Sai Ambati, Bazga Ali, Owen Seddon, et al.
Gut
|
December 31, 2011
Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer
Gareth Betts, Emma Jones, Syed Junaid, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 11, 2015
Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers
Christopher J Holland, Garry Dolton, Martin Scurr, et al.
Cancer Immunology Research
|
January 11, 2014
Escalating regulation of 5T4-specific IFN-γ<sup>+</sup> CD4<sup>+</sup> T cells distinguishes colorectal cancer patients from healthy controls and provides a target for <i>in vivo</i> therapy
Martin Scurr, Anja Bloom, Tom Pembroke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2017
Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer
Martin Scurr, Tom Pembroke, Anja Bloom, et al.
JAMA Oncology
|
September 8, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial
Martin Scurr, Tom Pembroke, Anja Bloom, et al.
Journal for Immunotherapy of Cancer
|
October 23, 2020
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
Sarah Nicol Lauder, Kathryn Smart, Veerle Kersemans, et al.
Journal of Clinical Immunology
|
June 10, 2024
Lower Humoral and Cellular Immunity Following Asymptomatic SARS-CoV-2 Infection Compared to Symptomatic Infection in Education (The ACE Cohort)
Georgina Hopkins, Nancy Gomez, Davis Tucis, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cellular Immunology
|
October 9, 2012
T cell subsets and colorectal cancer: discerning the good from the bad
Martin Scurr, Awen Gallimore, Andrew Godkin
Immunology
|
February 21, 2018
T-cell modulation by cyclophosphamide for tumour therapy
Ellyn Hughes, Martin Scurr, Emma Campbell, et al.
International Journal of Hematology
|
February 9, 2023
Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T
Sai Ambati, Bazga Ali, Owen Seddon, et al.
Gut
|
December 31, 2011
Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer
Gareth Betts, Emma Jones, Syed Junaid, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 11, 2015
Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers
Christopher J Holland, Garry Dolton, Martin Scurr, et al.
Cancer Immunology Research
|
January 11, 2014
Escalating regulation of 5T4-specific IFN-γ<sup>+</sup> CD4<sup>+</sup> T cells distinguishes colorectal cancer patients from healthy controls and provides a target for <i>in vivo</i> therapy
Martin Scurr, Anja Bloom, Tom Pembroke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2017
Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer
Martin Scurr, Tom Pembroke, Anja Bloom, et al.
JAMA Oncology
|
September 8, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical Trial
Martin Scurr, Tom Pembroke, Anja Bloom, et al.
Journal for Immunotherapy of Cancer
|
October 23, 2020
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
Sarah Nicol Lauder, Kathryn Smart, Veerle Kersemans, et al.
Journal of Clinical Immunology
|
June 10, 2024
Lower Humoral and Cellular Immunity Following Asymptomatic SARS-CoV-2 Infection Compared to Symptomatic Infection in Education (The ACE Cohort)
Georgina Hopkins, Nancy Gomez, Davis Tucis, et al.
Page
of 1